Prognostic Values Of Preoperative Serum CEA And CA125 Levels And Nomograms For Young Breast Cancer Patients
Xuan Li,Danian Dai,Bo Chen,Sirong He,Jie Zhang,Chunjie Wen,Bin Wang
DOI: https://doi.org/10.2147/OTT.S221335
IF: 4
2019-11-26
OncoTargets and Therapy
Abstract:Xuan Li, 1–3, * Danian Dai, 4, 5, * Bo Chen, 6, * Sirong He, 7 Jie Zhang, 3 Chunjie Wen, 5 Bin Wang 5 1 Department of Breast Surgery, Key Laboratory of Breast Cancer in Shanghai, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China; 2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China; 3 Department of Breast Oncology, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, People's Republic of China; 4 Department of Gynecology and Obstetrics, The Fifth Affiliated Hospital of Sun Yat-Sen University, Zhuhai, Guangdong 519000, People's Republic of China; 5 Institute of Life Sciences, Chongqing Medical University, Chongqing 400016, People's Republic of China; 6 Department of Breast Cancer, Cancer Center, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong 510080, People's Republic of China; 7 Department of Immunology, College of Basic Medicine, Chongqing Medical University, Chongqing 400016, People's Republic of China *These authors contributed equally to this work Correspondence: Bin Wang Institute of Life Sciences, Chongqing Medical University, No. 1 Yixueyuan Road, Yuzhong District, Chongqing 400016, People's Republic of China Tel +86 23 63662443 Email biowb@outlook.com Background: Young breast cancer patients have poor prognosis compared to older patients in both overall survival (OS) and loco-regional failure-free survival. Carcinoembryonic antigen (CEA) and Cancer antigen 125 (CA125) have been widely used, but their prognostic value in young breast cancer patients remains unknown. The objectives of this study were to evaluate the prognostic value of preoperative CEA and CA125 serum levels and to build nomograms for better prognostic prediction of young Chinese breast cancer patients using both tumor markers. Methods: We included 576 young breast cancer patients (≤40 years at diagnosis) and collected their preoperative information. The best cut-off values of the CEA and CA125 were identified with receiver operating characteristic (ROC) curves. Univariate and multivariate analyses were used to identify the relative risks of factors for the overall survival (OS), and disease-free survival (DFS), and nomograms were constructed based on these identified factors. Results: The best cut-off values for CEA and CA125 in young breast cancer patients was 3.38 ng/mL and 19.38 U/mL, respectively. Kaplan-Meier analysis showed that young patients with low levels of CEA and/or CA125, had longer OS and DFS. Multivariate analysis suggested that both CEA and CA125 levels were independent predictive elements for OS. Nomograms were built and showed a better predictive ability for OS (AUC = 0.856) and DFS (AUC = 0.702) in young breast cancer patients. Conclusion: Preoperative serum CEA and CA125 levels could be the independent prognostic factors for OS, and the nomograms including these two variables provide more personal forecasts information to help physicians optimize treatment for young breast cancer patients better. Keywords: young breast cancer patient, carcinoembryonic antigen, cancer antigen 125, prognostic factors
oncology,biotechnology & applied microbiology